- Report
- January 2025
- 28 Pages
Italy
From €1700EUR$2,047USD£1,521GBP
- Report
- January 2025
- 25 Pages
Japan
From €1700EUR$2,047USD£1,521GBP
- Report
- January 2025
- 25 Pages
Argentina
From €1700EUR$2,047USD£1,521GBP
- Report
- January 2025
- 22 Pages
Chile
From €1700EUR$2,047USD£1,521GBP
- Report
- January 2025
- 30 Pages
Portugal
From €1700EUR$2,047USD£1,521GBP
- Report
- January 2025
- 33 Pages
Canada
From €1700EUR$2,047USD£1,521GBP
- Report
- January 2025
- 25 Pages
Germany
From €1700EUR$2,047USD£1,521GBP
- Report
- January 2025
- 36 Pages
Switzerland
From €1700EUR$2,047USD£1,521GBP
- Report
- January 2025
- 27 Pages
Czech Republic
From €1700EUR$2,047USD£1,521GBP
- Report
- January 2025
- 28 Pages
Spain
From €1700EUR$2,047USD£1,521GBP
- Report
- January 2025
- 27 Pages
Belgium
From €1700EUR$2,047USD£1,521GBP
- Report
- December 2024
- 34 Pages
Canada
From €4445EUR$4,995USD£3,843GBP
- Report
- December 2024
- 31 Pages
Australia
From €4445EUR$4,995USD£3,843GBP
- Report
- December 2024
- 30 Pages
India
From €4445EUR$4,995USD£3,843GBP
- Report
- December 2024
- 31 Pages
Germany
From €4445EUR$4,995USD£3,843GBP
- Report
- December 2024
- 52 Pages
United States
From €1072EUR$1,205USD£927GBP
- Report
- December 2024
- 436 Pages
Global
From €3559EUR$4,000USD£3,078GBP
- Report
- December 2024
- 505 Pages
Global
From €3559EUR$4,000USD£3,078GBP
- Report
- December 2024
- 199 Pages
United States
From €4939EUR$5,550USD£4,270GBP
- Clinical Trials
- November 2024
- 893 Pages
Global
From €3070EUR$3,450USD£2,654GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more